Garrison Bradford & Associates’s Celgene Corp CELG Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q1 | – | Sell |
-59,050
| Closed | -$3.79M | – | 87 |
|
|
2018
Q4 | $3.79M | Sell |
59,050
-4,700
| -7% | -$301K | 3.42% | 6 |
|
|
2018
Q3 | $5.71M | Sell |
63,750
-700
| -1% | -$62.6K | 4.6% | 4 |
|
|
2018
Q2 | $5.12M | Sell |
64,450
-1,300
| -2% | -$103K | 4.2% | 5 |
|
|
2018
Q1 | $5.87M | Sell |
65,750
-4,450
| -6% | -$397K | 4.99% | 5 |
|
|
2017
Q4 | $7.33M | Sell |
70,200
-1,170
| -2% | -$122K | 6.06% | 4 |
|
|
2017
Q3 | $10.4M | Sell |
71,370
-600
| -0.8% | -$87.5K | 8.71% | 3 |
|
|
2017
Q2 | $9.35M | Sell |
71,970
-100
| -0.1% | -$13K | 8.09% | 3 |
|
|
2017
Q1 | $8.97M | Hold |
72,070
| – | – | 7.92% | 3 |
|
|
2016
Q4 | $8.34M | Buy |
72,070
+400
| +0.6% | +$46.3K | 7.69% | 3 |
|
|
2016
Q3 | $7.49M | Sell |
71,670
-1,600
| -2% | -$167K | 7.05% | 3 |
|
|
2016
Q2 | $7.23M | Sell |
73,270
-400
| -0.5% | -$39.5K | 7.08% | 3 |
|
|
2016
Q1 | $7.37M | Buy |
73,670
+6,070
| +9% | +$608K | 8.58% | 2 |
|
|
2015
Q4 | $8.1M | Sell |
67,600
-400
| -0.6% | -$47.9K | 9.07% | 2 |
|
|
2015
Q3 | $7.36M | Sell |
68,000
-200
| -0.3% | -$21.6K | 8.12% | 2 |
|
|
2015
Q2 | $7.89M | Sell |
68,200
-500
| -0.7% | -$57.9K | 7.71% | 2 |
|
|
2015
Q1 | $7.92M | Buy |
68,700
+900
| +1% | +$104K | 7.4% | 2 |
|
|
2014
Q4 | $7.58M | Buy |
67,800
+2,550
| +4% | +$285K | 6.87% | 2 |
|
|
2014
Q3 | $6.18M | Sell |
65,250
-550
| -0.8% | -$52.1K | 6.18% | 2 |
|
|
2014
Q2 | $5.65M | Sell |
65,800
-3,600
| -5% | -$309K | 5.26% | 3 |
|
|
2014
Q1 | $4.84M | Buy |
69,400
+3,600
| +5% | +$251K | 4.67% | 4 |
|
|
2013
Q4 | $5.56M | Buy |
65,800
+200
| +0.3% | +$16.9K | 5.25% | 2 |
|
|
2013
Q3 | $5.06M | Sell |
65,600
-1,000
| -2% | -$77.1K | 5.17% | 3 |
|
|
2013
Q2 | $3.9M | Buy |
+66,600
| New | +$3.9M | 4.19% | 5 |
|